Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

14C-Psilocin tissue distribution in pregnant rats after intravenous administration

F. C. P. Law, Grace K. Poon, Y. C. Chui, Shao-Xiong He

Functional Foods in Health and Disease July 27, 2014 DOI: 10.31989/ffhd.v4i6.9 (opens in new tab) via OpenAlex

Summary

AI-generated from the abstract

After intravenous injection into pregnant rats, psilocin—the main psychoactive compound in magic mushrooms—crossed the placental barrier and entered fetal tissues. Maternal tissue concentrations of the drug were much higher than fetal tissue concentrations, and psilocin was eliminated slowly from fetal tissues (elimination half-life greater than 13 hours), compared to faster elimination from maternal brain tissue (half-life less than 13 hours). A new metabolite, tentatively identified as dihydroxyindoleacetic acid, was found in rat urine. Because psilocin lingered in fetal tissues, the authors advise avoiding magic mushroom consumption during pregnancy.

Study at a glance

Characteristics Observational study Peer reviewed
Sample size 21
Population Pregnant and male Wistar rats
Dose 7.5 mg/kg 14C-psilocin i.v.; 15 mg/kg unlabeled psilocin i.p.
Duration 0.5 to 8.0 hours post-dosing for tissue study; urine collection period not specified
Topics Psilocybin
Keywords Urine Chemistry Metabolite Pharmacology
Citations 11
Key finding Psilocin readily crossed the placental and blood-brain barriers in pregnant rats and was eliminated slowly from fetal tissues, suggesting a risk of accumulation in the fetus.

Abstract

Background: Many species of hallucinogenic mushrooms have been found in the genus Psilocybe. The main psychoactive chemicals of Psilocybe mushrooms are psilocin and its phosphoryloxy derivative, psilocybin. In addition to its psychedelic effects, psilocybin is an effective agent to lift the mood of depressed patients with terminal cancers.Objective: To study the dispositional kinetics of 14C-psilocin in pregnant rats after intravenous injection, to calculate tissue dose surrogates i.e., tissue 14C concentration and area under the concentration-time curve using the experimental data, to quantify trans-placental passage of psilocin and/or its metabolites, and to identify new psilocin metabolite(s) in rat urine.Methods: A group of 15 pregnant Wistar rats weighing between 0.30-0.36 kg was used in the study. Each rat was given a single dose of 7.5 mg/kg 14C-psilocini.v. Three rats were randomly selected and sacrificed at 0.5, 1.0, 2.0, 4.0, and 8.0 hr post-dosing. The maternal and fetal tissues were quickly removed and the radioactivity in these tissues determined by liquid scintillation counting.In a separate study, urine samples were collected from 6 male Wistar rats after administering 15 mg/kg of unlabeled psilocin i.p. The urine samples were collected and extracted by chloroform-methanol (9:1 v/v) and analyzed using a gas chromatograph/mass spectrometer.Results: 14C-Psilocin crossed the placental barrier of pregnant rats readily after i.v. administration; maternal tissue 14C concentrations were found to be much higher than those in fetal tissues. The areas under the curve for maternal tissues also were much higher than the fetal tissues. In general, maternal tissues could be divided into the fast eliminating organ group, which included the brain (elimination half-life <13 hr) and the slow eliminating organ group, which included all fetal tissues (elimination half-life >13 hr). A new psilocin metabolite tentatively identified as dihydroxyindoleacetic acid was found in the urine.Conclusion: Our study showed that psilocin readily crossed the placental and blood-brain barriers of pregnant rats. Because psilocin was eliminated slowly from the fetal tissues of rats, human consumption of magic mushrooms should be avoided during pregnancy. Key words: magic mushrooms, psilocin, placental barrier, pregnant rats

Explore topics

Comments

No comments yet.

Log in to comment